GUTS compared with SYK: revenue, margins and what each company keeps, and the suppliers and customers both name

GUTSFractyl Health, Inc.

Mkt capRevenueRevenue

SYKStryker Corp

Mkt capRevenueRevenue

Compare

GUTSFractyl Health, Inc.

SYKStryker Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

GUTS1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▲+3.97%—

SYK

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.2%▼−6.38%×0.89

Q2 FY26±6.5%▼−6.42%×0.98

= impliedGUTS realized, solidSYK realized, hatchedOne scale, both sides: full bar = 8%× = |realized| ÷ impliedSource: market data

Q1 FY26

±5.8%

▼−6.47%

×1.12

Jan 30 '26±5.2%▲+4.31%×0.83

GUTSFractyl Health, Inc.

0.92▲+3.16%· post 0.92

Mkt cap$12.3MRevenue$3,000Q4 FY24Revenue$93,000FY24

SYKStryker Corp

325.40▼−2.89%· post 325.87

ClosedNov 6 '26

Mkt cap$124.1BRevenue$6.5BQ3 FY26Revenue$25.1BFY25

Compare

ClosedNov 6 '26

GUTSFractyl Health, Inc.

SYKStryker Corp

0.92▲+3.16%post 0.92

Price

325.40▼−2.89%post 325.87

$12.3M

Mkt cap

$124.1B

Q4 FY24$3,000

Revenue

$6.5BQ3 FY26

FY24$93,000

Revenue

$25.1BFY25

GUTS0.92▲+3.16%vsSYK325.40▼−2.89%ClosedNov 6 '26